Key result
Pharmacist education and cost handouts increase SGLT2 inhibitor prescribing in heart failure by ~27%.
Why the study?
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were underutilized in eligible patients with heart failure across the health system, prompting an effort to identify and address barriers to prescribing.
Does a multimodal quality improvement intervention involving pharmacist education to primary care providers and a cost information handout increase SGLT-2 inhibitor prescription rates in eligible patients with heart failure?
Does a multimodal quality improvement intervention involving pharmacist education to primary care providers and a cost information handout increase SGLT-2 inhibitor prescription rates in eligible patients with heart failure?
Answers are grounded in this paper and cite their sources.
A multimodal quality improvement approach involving pharmacist education for primary care providers and cost handouts resulted in a 26.8% relative increase in SGLT-2 inhibitor prescribing among eligible patients with heart failure.
OBJECTIVE: The objective of this quality improvement project was to identify and address barriers contributing to the underutilization of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in eligible patients with heart failure across the health system. METHODS: The heart failure registry was used to identify the prescription percentage of SGLT-2 inhibitors pre- and postintervention. Interventions to increase prescribing included pharmacist education to primary care providers and use of a cost information handout. RESULTS: Following the intervention, SGLT-2 inhibitor prescription for eligible patients improved from 7.1% (n = 630) to 9.0% (n = 814), representing a relative increase of 26.8% from baseline. CONCLUSION: A multimodal approach involving pharmacy and primary care effectively increased SGLT-2 inhibitor prescribing in patients with heart failure. Physician associates, a key part of the primary care workforce, play an important role initiating guideline-directed medical therapy.
No takes yet. Share an insight, caveat, or question.
Hoppe et al. (2026) studied Heart failure. Pharmacist education to primary care providers and cost information handout vs. Pre-intervention baseline was evaluated on Prescription percentage of SGLT-2 inhibitors in eligible patients with heart failure (Relative increase 26.8%). Pharmacist education to primary care providers and a cost handout increased SGLT-2 inhibitor prescribing in eligible heart failure patients from 7.1% to 9.0%.
Synapse has enriched 10 related papers. Consider them for comparative context: